Parasite | Eso | Sto | Cancer | ESD
[À§¾Ï 378 - À§¾Ï ÀÚ¿¬»ç. Natural history of gastric cancer]
001 | 101 | 201 | 301 | 401 | 501 | 601 | 701 | 801 | 901 | 1000
À§°¢ÀÇ ÇÔ¸ôÇü º´¼Ò¿¡¼ Á¶Á÷°Ë»çÇÏ¿© atypical cellÀÌ ÀÖ´Ù°í ÀǷڵǾú½À´Ï´Ù. °Ë»ç Á÷ÈĺÎÅÍ PPI¸¦ µå½Å °Í °°½À´Ï´Ù. ¾à 4ÁÖ ÈÄ ³»½Ã°æ¿¡¼ ±Ë¾çÇü º´¼Ò´Â °ÅÀÇ ¾Æ¹°¾î ÀÖ¾ú½À´Ï´Ù. ¿ÜºÎ Á¶Á÷°Ë»ç ÀçÆǵ¶°ú º» º´¿øÀÇ ³»½Ã°æ Á¶Á÷°Ë»ç Àç°Ë¿¡¼ ¸ðµÎ ¾ÏÀ¸·Î ³ª¿Í ¼ö¼úÀ» ÇÏ¿´½À´Ï´Ù. º» º´¿ø¿¡¼´Â PPI¸¦ µå¸®Áö ¾Ê¾Ò°í ¾à 2ÁÖ ÈÄ ¼ö¼úÇÏ¿´½À´Ï´Ù. ¼ö¼ú Àü³¯ clippingÀ» À§ÇÏ¿© ³»½Ã°æ Àç°ËÀ» ÇÏ¿´½À´Ï´Ù. 3¹øÀÇ ³»½Ã°æ »çÁøÀ» Àß º¸½Ã±â ¹Ù¶ø´Ï´Ù. Á¶±âÀ§¾ÏÀº natural history¿¡ ÀÇÇÏ¿© ¸ð¾çÀÌ º¯Çϱ⵵ ÇÏÁö¸¸ PPI µî ¾àÁ¦¿¡ ÀÇÇÑ ¿µÇâµµ »ó´çÇÕ´Ï´Ù.
Early gastric carcinoma
1. Location : lower third, Center at body and lesser curvature
2. Gross type : EGC type IIc and IIa
3. Histologic type : tubular adenocarcinoma, moderately differentiated
4. Histologic type by Lauren : intestinal
5. Size : 3.9x2.5 cm
6. Depth of invasion : invades mucosa (muscularis mucosae) (pT1a)
7. Resection margin: free from carcinoma, safety margin: proximal 3.5 cm, distal 6.3 cm
8. Lymph node metastasis : no metastasis in 65 regional lymph nodes (pN0)
9. Lymphatic invasion : not identified
10. Venous invasion : not identified
11. Perineural invasion : not identified
12. AJCC stage by 7th edition: pT1a N0
[ºñ±³Àû »¡¸® ÀÚ¶ú´ø Áõ·Ê]
70´ë ³²ÀÚÀÔ´Ï´Ù. Cardia¸¦ involveÇÏ´Â À§¾ÏÀ¸·Î ¼ö¼úÀ» ±ÇÇÏ¿´À¸³ª ¼ö¼úÇÏÁö ¾Ê°í °æ°ú°üÂûÀ» ¿øÇϽþî follow-up loss°¡ µÇ¾ú´Ù°¡ 1´Þ ÀüºÎÅÍ dysphagia°¡ ÀÖ¾î ÀÇ·ÚµÈ È¯ÀÚÀÔ´Ï´Ù. 18 °³¿ù Àü »çÁøÀ» º¸¸é º´¼ÒÀÇ distal marginÀº upper body¿Í mid-bodyÀÇ °æ°è Á¤µµ¿´À¸³ª ÃÖ±Ù ³»½Ã°æ¿¡¼´Â cardia involve°¡ ÀÖ¾ú°í (»çÁø»ý·«), angle±îÁö º´¼Ò°¡ ³Ð¾îÁ³½À´Ï´Ù. ºñ±³Àû ºü¸¥ ¼ÓµµÀÇ progressionÀ» º¸ÀÎ ÁøÇ༺À§¾ÏÀ̾ú´ø °ÍÀ¸·Î ÆÇ´ÜÇÏ¿´½À´Ï´Ù.
°ú°Å¿¡´Â °í·ÉÀÇ È¯Àڵ鿡°Ô ¼ö¼úÀ» ±ÇÇÏ´Â °ÍÀº ¸Å¿ì ¾î·Æ°í À§ÇèÇÑ ÀÏ·Î °£ÁֵǾú½À´Ï´Ù. ±×·¯³ª ÃÖ±Ù¿¡´Â °í·ÉÀÇ È¯ÀÚ¶ó°í ÇÏ´õ¶óµµ performance°¡ ÁÁÀº °æ¿ì´Â Àû±ØÀûÀÎ Ä¡·á¸¦ ±ÇÇÏ´Â °ÍÀÌ º¸ÅëÀÔ´Ï´Ù. ¼ö¼ú¿¡ µû¸¥ À§Ç輺Àº ½ÇÁ¦ ¿¬·Éº¸´Ù´Â cardiopulmonary function¿¡ ÀÇÇÏ¿© °áÁ¤µÇ´Â °ÍÀ¸·Î »ý°¢µÇ±â ¶§¹®ÀÔ´Ï´Ù. ¼ö¼úÀÌ °¡´ÉÇÑ ÁøÇ༺À§¾Ï ȯÀÚ¿¡¼ ÃÊ°í·É ȯÀÚ¶ó°í ÇÏ´õ¶óµµ Áß³â ȯÀÚ¿¡ ºñÇÏ¿© ¼ö¼ú¿¡ µû¸¥ morbidity¿Í mortality°¡ À¯ÀÇÇÑ Â÷ÀÌ°¡ ¾ø´Ù´Â °ÍÀº ¿©·¯ º¸°í¿¡¼ ¹Ýº¹ÀûÀ¸·Î È®Àεǰí ÀÖ½À´Ï´Ù.
¾î¶² ¼±»ý´ÔÀº ÀÌ·± ¸»¾¸À» Çϼ̽À´Ï´Ù. "³ªÀÌ´Â ´ÜÁö ¼ýÀÚÀÏ »ÓÀÌ´Ù."
[ÃßÁ¤ÄÁµ¥ Æò±Õ ȤÀº Æò±Õº¸´Ù ´Ù¼Ò ´À¸° ¼Óµµ·Î ÀÚ¶ú´ø Áõ·Ê]
70´ë ÃÊ¹Ý ³²¼ºÀÔ´Ï´Ù. 2010³â adenocarcinoma (P/D)°¡ ¹ß°ßµÇ¾ú½À´Ï´Ù. 6³â ÈÄ obstruction Áõ¼¼¿Í ÇÔ²² ³»¿øÇÏ¿´À» ¶§´Â À§ proximal 2/3¸¦ °ÅÀÇ ´Ù Â÷ÁöÇÏ´Â ½ÉÇÑ AGC°¡ µÇ¾î ÀÖ¾ú½À´Ï´Ù.
1) Á¶±â À§¾ÏÀÇ ÀÚ¿¬»ç´Â ¿¹Ãø °¡´ÉÇÑ°¡? ÀÌ»ó±æ. ´ëÇѼÒȱâÇÐȸÁö 2012
© 2016-4-7. ÀÏ¿ø³»½Ã°æ±³½Ç ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò ÀÌÁØÇà